Your browser doesn't support javascript.
loading
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.
Lazaryan, Aleksandr; Dolan, Michelle; Zhang, Mei-Jie; Wang, Hai-Lin; Kharfan-Dabaja, Mohamed A; Marks, David I; Bejanyan, Nelli; Copelan, Edward; Majhail, Navneet S; Waller, Edmund K; Chao, Nelson; Prestidge, Tim; Nishihori, Taiga; Kebriaei, Partow; Inamoto, Yoshihiro; Hamilton, Betty; Hashmi, Shahrukh K; Kamble, Rammurti T; Bacher, Ulrike; Hildebrandt, Gerhard C; Stiff, Patrick J; McGuirk, Joseph; Aldoss, Ibrahim; Beitinjaneh, Amer M; Muffly, Lori; Vij, Ravi; Olsson, Richard F; Byrne, Michael; Schultz, Kirk R; Aljurf, Mahmoud; Seftel, Matthew; Savoie, Mary Lynn; Savani, Bipin N; Verdonck, Leo F; Cairo, Mitchell S; Hossain, Nasheed; Bhatt, Vijaya Raj; Frangoul, Haydar A; Abdel-Azim, Hisham; Al Malki, Monzr; Munker, Reinhold; Rizzieri, David; Khera, Nandita; Nakamura, Ryotaro; Ringdén, Olle; Van der Poel, Marjolein; Murthy, Hemant S; Liu, Hongtao; Mori, Shahram; De Oliveira, Satiro.
Afiliação
  • Lazaryan A; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Dolan M; University of Minnesota Medical Center, Minneapolis, MN, USA.
  • Zhang MJ; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Wang HL; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.
  • Marks DI; Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, UK.
  • Bejanyan N; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.
  • Copelan E; Levine Cancer Institute, Atrium Health, Carolinas HealthCare System, Charlotte, NC, USA.
  • Majhail NS; Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Waller EK; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Chao N; Division of Cell Therapy and Hematology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
  • Prestidge T; Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand.
  • Nishihori T; Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Kebriaei P; Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, TX, USA.
  • Inamoto Y; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Hamilton B; Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Hashmi SK; Department of Internal Medicine, Mayo Clinic, MN, USA; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Kamble RT; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Bacher U; Department of Hematology, Inselspital, Bern University Hospital, Switzerland.
  • Hildebrandt GC; Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
  • Stiff PJ; Loyola University Medical Center, Maywood, IL, USA.
  • McGuirk J; University of Kansas Medical Center, Westwood, KS, USA.
  • Aldoss I; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Beitinjaneh AM; University of Miami, Miami, FL, USA.
  • Muffly L; Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA, USA.
  • Vij R; Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, MO, USA.
  • Olsson RF; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
  • Byrne M; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Schultz KR; Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Aljurf M; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Seftel M; Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
  • Savoie ML; Tom Baker Cancer Centre, Calgary, Alberta, Canada.
  • Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Verdonck LF; Department of Hematology/Oncology, Isala Clinic, Zwolle, the Netherlands.
  • Cairo MS; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY, USA.
  • Hossain N; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.
  • Bhatt VR; The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
  • Frangoul HA; The Children's Hospital at TriStar Centennial and Sarah Cannon Research Institute, Nashville, TN, USA.
  • Abdel-Azim H; Division of Hematology, Oncology and Blood and Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
  • Al Malki M; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Munker R; Section of Hematology/Oncology, Department of Internal Medicine, Louisiana State University Health Shreveport, Shreveport, LA, USA.
  • Rizzieri D; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA.
  • Khera N; Department of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Nakamura R; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.
  • Ringdén O; Translational Cell Therapy Group, CLINTEC (Clinical Science, Intervention and Technology), Karolinska Institutet, Stockholm Sweden.
  • Van der Poel M; Academische Ziekenhuis Maastricht, Maastricht, the Netherlands.
  • Murthy HS; Mayo Clinic Florida, Jacksonville, FL, USA.
  • Liu H; University of Chicago Medicine, Chicago, IL, USA.
  • Mori S; Blood and Marrow Transplant Center, Florida Hospital Medical Group, Orlando, FL, USA.
  • De Oliveira S; UCLA Medical Center, Los Angeles, CA, USA.
Haematologica ; 106(8): 2295-2296, 2021 08 01.
Article em En | MEDLINE | ID: mdl-34333962
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Adult / Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Adult / Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos